Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1986-8-18
|
pubmed:abstractText |
Estrogen receptor (ER) levels were measured in 280 breast cancer patients (mean age 54.5 years). Progesterone receptor (PR) levels were assayed in 101 of them. 61.4% of cases were at stages I and IIa. No significant difference in 2-year survival was established between ER-negative and ER-positive patients (96.7 and 96.0%, respectively). Two-year survival rate and recurrence--free survival for PR-positive cases were significantly higher than those for PR-negative ones (p greater than 0.05).
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0507-3758
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
71-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3727485-Breast Neoplasms,
pubmed-meshheading:3727485-Female,
pubmed-meshheading:3727485-Humans,
pubmed-meshheading:3727485-Lymphatic Metastasis,
pubmed-meshheading:3727485-Mastectomy,
pubmed-meshheading:3727485-Neoplasm Staging,
pubmed-meshheading:3727485-Prognosis,
pubmed-meshheading:3727485-Receptors, Estradiol,
pubmed-meshheading:3727485-Receptors, Estrogen,
pubmed-meshheading:3727485-Receptors, Progesterone
|
pubmed:year |
1986
|
pubmed:articleTitle |
[Steroid hormone receptors and survival in breast cancer patients].
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|